<DOC>
	<DOC>NCT01131182</DOC>
	<brief_summary>This study will examine whether the incidence of hypoglycemia in patients fasting for Ramadan is lower when treated with sitagliptin as compared to sulfonylurea treatment.</brief_summary>
	<brief_title>Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)</brief_title>
	<detailed_description>This study and NCT01340768 (MK-0431-262) have the same design but are conducted under separate protocols, in different countries, according to local guidelines.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Muslim men and women with type 2 diabetes Participants who intend to fast during the month of Ramadan Participants who have been on a stable dose of sulfonylurea for at least three months Participants with type 1 diabetes mellitus Pregnant or breast feeding women Participants with hypersensitivity or contraindication to dipeptidyl peptidase (DPP4) treatment Participants on insulin Participants on any class of oral diabetic therapy other than sulfonylurea or metformin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>